Austar Lifesciences Limited (SEHK: 6118)
Health Care · Life Sciences Tools & Services · CN
HK$0.70
-2.78% today · -50.7% 1Y
Austar Lifesciences Limited (SEHK: 6118) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $45.72M and employs 1,468 people.
Over the last twelve months the share price has lost 50.7%, trading between 0.65 and 1.53.
Tweenvest scores Austar Lifesciences Limited across four factors: quality 65/100, value 58/100, growth 21/100. Its strongest factor is quality.
6118 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $45.72M
- Revenue (TTM)
- $237.49M
- P/E
- 18.00
- EPS
- 0.03
- Dividend yield
- —
- Beta (5Y)
- 0.89
- 52-week high
- HK$1.53
- 52-week low
- HK$0.65
- Avg volume (3M)
- —
- Shares outstanding
- 512.58M
- Employees
- 1,468
- Next earnings
- —
About Austar Lifesciences Limited
Austar Lifesciences Limited functions as an investment holding company, delivering integrated engineering and technology solutions to pharmaceutical production facilities and research institutions globally, with a significant presence in Mainland China. Its business activities are structured across six primary divisions: liquid and bioprocessing systems; controlled environment and automated monitoring systems; powder and solid material handling systems; Good Manufacturing Practice (GMP) adherence services; life science expendables; and the brokerage and supply of pharmaceutical machinery. The company's product portfolio is extensive, including systems for pharmaceutical water, liquid preparation, and bioprocessing; powder and solid processing units; clean utility infrastructure; and advanced cleanroom technology. They also supply automated control and monitoring systems, freeze-dryers, sterile filling equipment, and visual inspection apparatus. Furthermore, Austar provides products for pharmaceutical contamination control, aseptic packaging and containment, biosafety and lab animal equipment and consumables, single-use bioprocess components, and offers holistic laboratory setup solutions. Beyond its product offerings, Austar Lifesciences extends a wide array of professional services, such as design and engineering, quality risk management, expert consultation, research and development assistance, process optimization, and digitalization strategies. The company also offers post-sale support, on-site services, system upgrades, facility relocation guidance, and comprehensive asset management. Additionally, it serves as an agent and distributor for pharmaceutical equipment, providing associated assembly and pre-assembly services. Established in 1991, Austar Lifesciences Limited is headquartered in Shanghai, China.
- ISIN
- KYG0632L1023
- Founded
- 1991
- Listed since
- Nov 7, 2014
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| hVIVO plcAIM: HVO | $54.55M | £0.06 | -1.67% |
| Carna Biosciences, Inc.TSE: 4572 | $49.53M | ¥368.00 | -10.90% |
| ENCell Co., Ltd.KOSDAQ: A456070 | $48.16M | ₩5,870.00 | -2.17% |
| Chiome Bioscience Inc.TSE: 4583 | $46.85M | ¥94.00 | -7.84% |
| Rapid Micro Biosystems, Inc.NasdaqCM: RPID | $44.82M | $0.87 | -3.12% |
| Abnova (Taiwan) CorporationTWSE: 4133 | $42.89M | NT$22.65 | +10.76% |
| Eone Diagnomics Genome Center Co., Ltd.KOSDAQ: A245620 | $42.41M | ₩— | — |
| Macter International LimitedKASE: MACTER | $41.22M | PKRs249.15 | -1.90% |
Figures last refreshed Oct 11, 2026.